looks like the recent ann is gaining some traction in the market .
A friend of mine had this to say about a year ago: (i know nothing about PAB or biotech stuff, but he does..)
"PAB highly speculative - but as far as biotechs go: in terms of concept/technology/antibody discovery platform etc + share price/market cap + risk and potential reward - this is a very interesting stock. If PAB are able to raise some more capital + have favourable trial results, then the sky is the limit for this stock!"
Well, they raised more capital and have had favourable trial results....so I guess my mate was right eh? The only thing holding PAB back it would seem , is just visability in the market ? Someone get AFR to do an article !
2nd patient with stable disease, page-74
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.37M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 5101591 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1558945 | 5 |
View Market Depth
| Last trade - 16.12pm 17/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable